HMGB1 and non-small cell lung carcinoma: Inhibiting HMGB1 prevented the development of pulmonary fibrosis in rats induced by bleomycin (Zhang et al., 2015), also inhibited the EMT progress in NSCLC cells and weakened their invasion and migration abilities (Liu et al., 2017).